← Back to Clinical Trials
Recruiting NCT07291453

NCT07291453 Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07291453
Status Recruiting
Phase —
Sponsor Okinawa Institute of Science and Technology Graduate University
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 250 participants
Start Date 2025-10-04
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Behavioral Parent Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 250 participants in total. It began in 2025-10-04 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates the feasibility and preliminary impacts of a new parent support program consisting of a series of educational videos, automatically delivered via a popular texting platform. The program content is focused on teaching parents strategies to better manage interactions with children in challenging situations many children experience, e.g., a transition to a non-preferred activity, waiting for delayed reward. Parents with children demonstrating inattentive, hyperactive and impulsive behavior and experiencing difficulties with these daily challenges are invited to participate in the study.

Eligibility Criteria

Inclusion Criteria: \- Parents with children aged 4-10 who experience difficulties in situations targeted by the program. \*Note: The program will be advertised that it was developed targeting children demonstrating behaviors consistent with ADHD, and the ADHD symptoms will be measured pre-post. However, children are not required to have a diagnosis of ADHD or show elevated levels of ADHD symptoms for the mothers to sign up. Exclusion Criteria: \- Parents who do not understand Japanese (the language the program is offered in).

Contact & Investigator

Central Contact

Emi Furukawa, PhD

✉ lovinghabits@oist.jp

📞 +81989668814

Frequently Asked Questions

Who can join the NCT07291453 clinical trial?

This trial is open to participants of all sexes, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07291453 currently recruiting?

Yes, NCT07291453 is actively recruiting participants. Contact the research team at lovinghabits@oist.jp for enrollment information.

Where is the NCT07291453 trial being conducted?

This trial is being conducted at Onna, Japan.

Who is sponsoring the NCT07291453 clinical trial?

NCT07291453 is sponsored by Okinawa Institute of Science and Technology Graduate University. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology